Stocks

U.S. Markets

Dimming prospects for a large fiscal stimulus package sends investors into U.S. government bonds, pushing yields lower.

IPOs

Chinese e-commerce group JD.com gave billionaire boss Richard Liu options to buy 2% stakes in its health and logistics units, an award that could enable him to accumulate holdings worth more than $1 billion.

U.S. Markets

The Dow Jones Industrial Average pared losses, but finished lower a day after closing just shy of its 30000-point milestone on optimism about new Covid-19 vaccines.

U.S. Markets

The Dow industrials and S&P 500 rose following positive study results from another potential Covid-19 vaccine, putting the blue-chip index within striking distance of 30000.

U.S. Markets

Technology stocks were among this week’s laggards as investors shifted bets to economically sensitive sectors such as banks and energy.

IPOs

The food-delivery company, which has grown at a blistering pace during the pandemic, turned a surprising quarterly profit in June before falling back to a loss in September.

U.S. Markets

New curbs on activity in New York and rising coronavirus infection levels across the U.S. triggered concerns about another blow to the economy.

U.S. Markets

Technology shares helped push the S&P 500 higher after lagging in recent days as promising vaccine developments elevated the prospects of economically-sensitive companies.

U.S. Markets

The blue-chip index outpaced the broader S&P 500 and Nasdaq Composite Index for a second consecutive day as investors reordered the market’s winners and losers.

U.S. Markets

U.S. stocks flirted with record levels after Democrat Joe Biden’s electoral victory and a vaccine developed by Pfizer and BioNTech proved better than expected at protecting people from Covid-19 in a pivotal study.

U.S. Markets

S&P 500 futures rallied sharply after progress toward a Covid-19 vaccine give markets fresh impetus.